Clinical Trials Directory

Trials / Unknown

UnknownNCT04901364

Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN)

Sensitivity and Specificity Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN)

Status
Unknown
Phase
Study type
Observational
Enrollment
57 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cystic lesions of the pancreas are frequent with a risk of degeneration into adenocarcinoma with pejorative prognosis. IPMNs require characterization to clarify their potential for degeneration. Clinical and morphological risk factors for degeneration determine the monitoring rate and the indication for pancreatic surgery. Pancreatic surgery remains invasive with high morbidity and mortality rates.

Detailed description

This is a monoservice and monocentric retrospective study at the Nancy CHRU. We will study the risk factors for IPMNs degeneration in order to determine the most sensitive and specific. To do this, we will use high-grade dysplasia or invasive cancer on the histological analysis of surgical specimens as the primary endpoint. The study population will be patients with Branch Duct, Main Duct or mixed IPMNs operated at the Nancy CHRU between September 2009 and October 2021.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSensitivity and specificity of risk factors for degeneration of IPMNsMeasurement of high-grade dysplasia or invasive cancer on the histological analysis of the surgical specimen

Timeline

Start date
2021-05-10
Primary completion
2021-09-30
Completion
2021-10-30
First posted
2021-05-25
Last updated
2021-05-25

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04901364. Inclusion in this directory is not an endorsement.